Report Overview
Immune therapy is a new class of cancer treatment designed to boost or enhance the body�s immune system to more efficiently target and destroy cancerous cells. Many experts believe that immunotherapy represents the most promising new cancer treatment since the development of chemotherapy.
The global Immunocell Therapy market size was estimated at USD 1876 million in 2023 and is projected to reach USD 5635.58 million by 2032, exhibiting a CAGR of 13.00% during the forecast period.
North America Immunocell Therapy market size was estimated at USD 603.84 million in 2023, at a CAGR of 11.14% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Immunocell Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Immunocell Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Immunocell Therapy market in any manner.
Global Immunocell Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
Autolus Therapeutics(Pipeline)
Sorrento Therapeutics(Pipeline)
Mustang Bio(Pipeline)
Bluebird Bio(Pipeline)
Cellectis(Pipeline)
Allogene Therapeutics(Pipeline)
Celyad(Pipeline)
Market Segmentation (by Type)
Chimeric Antigen Receptor (CAR) T Cell Therapy
Natural Killer (NK) Cell Therapy
Others
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
� North America (USA, Canada, Mexico)
� Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
� Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
� South America (Brazil, Argentina, Columbia, Rest of South America)
� The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
� Industry drivers, restraints, and opportunities covered in the study
� Neutral perspective on the market performance
� Recent industry trends and developments
� Competitive landscape & strategies of key players
� Potential & niche segments and regions exhibiting promising growth covered
� Historical, current, and projected market size, in terms of value
� In-depth analysis of the Immunocell Therapy Market
� Overview of the regional outlook of the Immunocell Therapy Market:
Key Reasons to Buy this Report:
� Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
� This enables you to anticipate market changes to remain ahead of your competitors
� You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
� The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
� Provision of market value data for each segment and sub-segment
� Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
� Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
� Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
� Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
� The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
� Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
� Provides insight into the market through Value Chain
� Market dynamics scenario, along with growth opportunities of the market in the years to come
� 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immunocell Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Immunocell Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Immunocell Therapy
1.2 Key Market Segments
1.2.1 Immunocell Therapy Segment by Type
1.2.2 Immunocell Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Immunocell Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Immunocell Therapy Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Immunocell Therapy Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Immunocell Therapy Market Competitive Landscape
3.1 Global Immunocell Therapy Sales by Manufacturers (2019-2025)
3.2 Global Immunocell Therapy Revenue Market Share by Manufacturers (2019-2025)
3.3 Immunocell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Immunocell Therapy Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Immunocell Therapy Sales Sites, Area Served, Product Type
3.6 Immunocell Therapy Market Competitive Situation and Trends
3.6.1 Immunocell Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Immunocell Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Immunocell Therapy Industry Chain Analysis
4.1 Immunocell Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Immunocell Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Immunocell Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immunocell Therapy Sales Market Share by Type (2019-2025)
6.3 Global Immunocell Therapy Market Size Market Share by Type (2019-2025)
6.4 Global Immunocell Therapy Price by Type (2019-2025)
7 Immunocell Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immunocell Therapy Market Sales by Application (2019-2025)
7.3 Global Immunocell Therapy Market Size (M USD) by Application (2019-2025)
7.4 Global Immunocell Therapy Sales Growth Rate by Application (2019-2025)
8 Immunocell Therapy Market Consumption by Region
8.1 Global Immunocell Therapy Sales by Region
8.1.1 Global Immunocell Therapy Sales by Region
8.1.2 Global Immunocell Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Immunocell Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Immunocell Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Immunocell Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Immunocell Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Immunocell Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Immunocell Therapy Market Production by Region
9.1 Global Production of Immunocell Therapy by Region (2019-2025)
9.2 Global Immunocell Therapy Revenue Market Share by Region (2019-2025)
9.3 Global Immunocell Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Immunocell Therapy Production
9.4.1 North America Immunocell Therapy Production Growth Rate (2019-2025)
9.4.2 North America Immunocell Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Immunocell Therapy Production
9.5.1 Europe Immunocell Therapy Production Growth Rate (2019-2025)
9.5.2 Europe Immunocell Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Immunocell Therapy Production (2019-2025)
9.6.1 Japan Immunocell Therapy Production Growth Rate (2019-2025)
9.6.2 Japan Immunocell Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Immunocell Therapy Production (2019-2025)
9.7.1 China Immunocell Therapy Production Growth Rate (2019-2025)
9.7.2 China Immunocell Therapy Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Novartis
10.1.1 Novartis Immunocell Therapy Basic Information
10.1.2 Novartis Immunocell Therapy Product Overview
10.1.3 Novartis Immunocell Therapy Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis Immunocell Therapy SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 Gilead Sciences
10.2.1 Gilead Sciences Immunocell Therapy Basic Information
10.2.2 Gilead Sciences Immunocell Therapy Product Overview
10.2.3 Gilead Sciences Immunocell Therapy Product Market Performance
10.2.4 Gilead Sciences Business Overview
10.2.5 Gilead Sciences Immunocell Therapy SWOT Analysis
10.2.6 Gilead Sciences Recent Developments
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Immunocell Therapy Basic Information
10.3.2 Bristol-Myers Squibb Immunocell Therapy Product Overview
10.3.3 Bristol-Myers Squibb Immunocell Therapy Product Market Performance
10.3.4 Bristol-Myers Squibb Immunocell Therapy SWOT Analysis
10.3.5 Bristol-Myers Squibb Business Overview
10.3.6 Bristol-Myers Squibb Recent Developments
10.4 J and J
10.4.1 J and J Immunocell Therapy Basic Information
10.4.2 J and J Immunocell Therapy Product Overview
10.4.3 J and J Immunocell Therapy Product Market Performance
10.4.4 J and J Business Overview
10.4.5 J and J Recent Developments
10.5 JW Therapeutics
10.5.1 JW Therapeutics Immunocell Therapy Basic Information
10.5.2 JW Therapeutics Immunocell Therapy Product Overview
10.5.3 JW Therapeutics Immunocell Therapy Product Market Performance
10.5.4 JW Therapeutics Business Overview
10.5.5 JW Therapeutics Recent Developments
10.6 FOSUNKite
10.6.1 FOSUNKite Immunocell Therapy Basic Information
10.6.2 FOSUNKite Immunocell Therapy Product Overview
10.6.3 FOSUNKite Immunocell Therapy Product Market Performance
10.6.4 FOSUNKite Business Overview
10.6.5 FOSUNKite Recent Developments
10.7 CARsgen Therapeutics (Pipeline)
10.7.1 CARsgen Therapeutics (Pipeline) Immunocell Therapy Basic Information
10.7.2 CARsgen Therapeutics (Pipeline) Immunocell Therapy Product Overview
10.7.3 CARsgen Therapeutics (Pipeline) Immunocell Therapy Product Market Performance
10.7.4 CARsgen Therapeutics (Pipeline) Business Overview
10.7.5 CARsgen Therapeutics (Pipeline) Recent Developments
10.8 Autolus Therapeutics(Pipeline)
10.8.1 Autolus Therapeutics(Pipeline) Immunocell Therapy Basic Information
10.8.2 Autolus Therapeutics(Pipeline) Immunocell Therapy Product Overview
10.8.3 Autolus Therapeutics(Pipeline) Immunocell Therapy Product Market Performance
10.8.4 Autolus Therapeutics(Pipeline) Business Overview
10.8.5 Autolus Therapeutics(Pipeline) Recent Developments
10.9 Sorrento Therapeutics(Pipeline)
10.9.1 Sorrento Therapeutics(Pipeline) Immunocell Therapy Basic Information
10.9.2 Sorrento Therapeutics(Pipeline) Immunocell Therapy Product Overview
10.9.3 Sorrento Therapeutics(Pipeline) Immunocell Therapy Product Market Performance
10.9.4 Sorrento Therapeutics(Pipeline) Business Overview
10.9.5 Sorrento Therapeutics(Pipeline) Recent Developments
10.10 Mustang Bio(Pipeline)
10.10.1 Mustang Bio(Pipeline) Immunocell Therapy Basic Information
10.10.2 Mustang Bio(Pipeline) Immunocell Therapy Product Overview
10.10.3 Mustang Bio(Pipeline) Immunocell Therapy Product Market Performance
10.10.4 Mustang Bio(Pipeline) Business Overview
10.10.5 Mustang Bio(Pipeline) Recent Developments
10.11 Bluebird Bio(Pipeline)
10.11.1 Bluebird Bio(Pipeline) Immunocell Therapy Basic Information
10.11.2 Bluebird Bio(Pipeline) Immunocell Therapy Product Overview
10.11.3 Bluebird Bio(Pipeline) Immunocell Therapy Product Market Performance
10.11.4 Bluebird Bio(Pipeline) Business Overview
10.11.5 Bluebird Bio(Pipeline) Recent Developments
10.12 Cellectis(Pipeline)
10.12.1 Cellectis(Pipeline) Immunocell Therapy Basic Information
10.12.2 Cellectis(Pipeline) Immunocell Therapy Product Overview
10.12.3 Cellectis(Pipeline) Immunocell Therapy Product Market Performance
10.12.4 Cellectis(Pipeline) Business Overview
10.12.5 Cellectis(Pipeline) Recent Developments
10.13 Allogene Therapeutics(Pipeline)
10.13.1 Allogene Therapeutics(Pipeline) Immunocell Therapy Basic Information
10.13.2 Allogene Therapeutics(Pipeline) Immunocell Therapy Product Overview
10.13.3 Allogene Therapeutics(Pipeline) Immunocell Therapy Product Market Performance
10.13.4 Allogene Therapeutics(Pipeline) Business Overview
10.13.5 Allogene Therapeutics(Pipeline) Recent Developments
10.14 Celyad(Pipeline)
10.14.1 Celyad(Pipeline) Immunocell Therapy Basic Information
10.14.2 Celyad(Pipeline) Immunocell Therapy Product Overview
10.14.3 Celyad(Pipeline) Immunocell Therapy Product Market Performance
10.14.4 Celyad(Pipeline) Business Overview
10.14.5 Celyad(Pipeline) Recent Developments
11 Immunocell Therapy Market Forecast by Region
11.1 Global Immunocell Therapy Market Size Forecast
11.2 Global Immunocell Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Immunocell Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Immunocell Therapy Market Size Forecast by Region
11.2.4 South America Immunocell Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Immunocell Therapy by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Immunocell Therapy Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Immunocell Therapy by Type (2025-2032)
12.1.2 Global Immunocell Therapy Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Immunocell Therapy by Type (2025-2032)
12.2 Global Immunocell Therapy Market Forecast by Application (2025-2032)
12.2.1 Global Immunocell Therapy Sales (K Units) Forecast by Application
12.2.2 Global Immunocell Therapy Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Immunocell Therapy Market Size Comparison by Region (M USD)
Table 5. Global Immunocell Therapy Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Immunocell Therapy Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Immunocell Therapy Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Immunocell Therapy Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunocell Therapy as of 2022)
Table 10. Global Market Immunocell Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Immunocell Therapy Sales Sites and Area Served
Table 12. Manufacturers Immunocell Therapy Product Type
Table 13. Global Immunocell Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Immunocell Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Immunocell Therapy Market Challenges
Table 22. Global Immunocell Therapy Sales by Type (K Units)
Table 23. Global Immunocell Therapy Market Size by Type (M USD)
Table 24. Global Immunocell Therapy Sales (K Units) by Type (2019-2025)
Table 25. Global Immunocell Therapy Sales Market Share by Type (2019-2025)
Table 26. Global Immunocell Therapy Market Size (M USD) by Type (2019-2025)
Table 27. Global Immunocell Therapy Market Size Share by Type (2019-2025)
Table 28. Global Immunocell Therapy Price (USD/Unit) by Type (2019-2025)
Table 29. Global Immunocell Therapy Sales (K Units) by Application
Table 30. Global Immunocell Therapy Market Size by Application
Table 31. Global Immunocell Therapy Sales by Application (2019-2025) & (K Units)
Table 32. Global Immunocell Therapy Sales Market Share by Application (2019-2025)
Table 33. Global Immunocell Therapy Sales by Application (2019-2025) & (M USD)
Table 34. Global Immunocell Therapy Market Share by Application (2019-2025)
Table 35. Global Immunocell Therapy Sales Growth Rate by Application (2019-2025)
Table 36. Global Immunocell Therapy Sales by Region (2019-2025) & (K Units)
Table 37. Global Immunocell Therapy Sales Market Share by Region (2019-2025)
Table 38. North America Immunocell Therapy Sales by Country (2019-2025) & (K Units)
Table 39. Europe Immunocell Therapy Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Immunocell Therapy Sales by Region (2019-2025) & (K Units)
Table 41. South America Immunocell Therapy Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Immunocell Therapy Sales by Region (2019-2025) & (K Units)
Table 43. Global Immunocell Therapy Production (K Units) by Region (2019-2025)
Table 44. Global Immunocell Therapy Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Immunocell Therapy Revenue Market Share by Region (2019-2025)
Table 46. Global Immunocell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Immunocell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Immunocell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Immunocell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Immunocell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Novartis Immunocell Therapy Basic Information
Table 52. Novartis Immunocell Therapy Product Overview
Table 53. Novartis Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Novartis Business Overview
Table 55. Novartis Immunocell Therapy SWOT Analysis
Table 56. Novartis Recent Developments
Table 57. Gilead Sciences Immunocell Therapy Basic Information
Table 58. Gilead Sciences Immunocell Therapy Product Overview
Table 59. Gilead Sciences Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Gilead Sciences Business Overview
Table 61. Gilead Sciences Immunocell Therapy SWOT Analysis
Table 62. Gilead Sciences Recent Developments
Table 63. Bristol-Myers Squibb Immunocell Therapy Basic Information
Table 64. Bristol-Myers Squibb Immunocell Therapy Product Overview
Table 65. Bristol-Myers Squibb Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Bristol-Myers Squibb Immunocell Therapy SWOT Analysis
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb Recent Developments
Table 69. J and J Immunocell Therapy Basic Information
Table 70. J and J Immunocell Therapy Product Overview
Table 71. J and J Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. J and J Business Overview
Table 73. J and J Recent Developments
Table 74. JW Therapeutics Immunocell Therapy Basic Information
Table 75. JW Therapeutics Immunocell Therapy Product Overview
Table 76. JW Therapeutics Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. JW Therapeutics Business Overview
Table 78. JW Therapeutics Recent Developments
Table 79. FOSUNKite Immunocell Therapy Basic Information
Table 80. FOSUNKite Immunocell Therapy Product Overview
Table 81. FOSUNKite Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. FOSUNKite Business Overview
Table 83. FOSUNKite Recent Developments
Table 84. CARsgen Therapeutics (Pipeline) Immunocell Therapy Basic Information
Table 85. CARsgen Therapeutics (Pipeline) Immunocell Therapy Product Overview
Table 86. CARsgen Therapeutics (Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. CARsgen Therapeutics (Pipeline) Business Overview
Table 88. CARsgen Therapeutics (Pipeline) Recent Developments
Table 89. Autolus Therapeutics(Pipeline) Immunocell Therapy Basic Information
Table 90. Autolus Therapeutics(Pipeline) Immunocell Therapy Product Overview
Table 91. Autolus Therapeutics(Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Autolus Therapeutics(Pipeline) Business Overview
Table 93. Autolus Therapeutics(Pipeline) Recent Developments
Table 94. Sorrento Therapeutics(Pipeline) Immunocell Therapy Basic Information
Table 95. Sorrento Therapeutics(Pipeline) Immunocell Therapy Product Overview
Table 96. Sorrento Therapeutics(Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Sorrento Therapeutics(Pipeline) Business Overview
Table 98. Sorrento Therapeutics(Pipeline) Recent Developments
Table 99. Mustang Bio(Pipeline) Immunocell Therapy Basic Information
Table 100. Mustang Bio(Pipeline) Immunocell Therapy Product Overview
Table 101. Mustang Bio(Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Mustang Bio(Pipeline) Business Overview
Table 103. Mustang Bio(Pipeline) Recent Developments
Table 104. Bluebird Bio(Pipeline) Immunocell Therapy Basic Information
Table 105. Bluebird Bio(Pipeline) Immunocell Therapy Product Overview
Table 106. Bluebird Bio(Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. Bluebird Bio(Pipeline) Business Overview
Table 108. Bluebird Bio(Pipeline) Recent Developments
Table 109. Cellectis(Pipeline) Immunocell Therapy Basic Information
Table 110. Cellectis(Pipeline) Immunocell Therapy Product Overview
Table 111. Cellectis(Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 112. Cellectis(Pipeline) Business Overview
Table 113. Cellectis(Pipeline) Recent Developments
Table 114. Allogene Therapeutics(Pipeline) Immunocell Therapy Basic Information
Table 115. Allogene Therapeutics(Pipeline) Immunocell Therapy Product Overview
Table 116. Allogene Therapeutics(Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 117. Allogene Therapeutics(Pipeline) Business Overview
Table 118. Allogene Therapeutics(Pipeline) Recent Developments
Table 119. Celyad(Pipeline) Immunocell Therapy Basic Information
Table 120. Celyad(Pipeline) Immunocell Therapy Product Overview
Table 121. Celyad(Pipeline) Immunocell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 122. Celyad(Pipeline) Business Overview
Table 123. Celyad(Pipeline) Recent Developments
Table 124. Global Immunocell Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 125. Global Immunocell Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 126. North America Immunocell Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 127. North America Immunocell Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 128. Europe Immunocell Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 129. Europe Immunocell Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 130. Asia Pacific Immunocell Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 131. Asia Pacific Immunocell Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 132. South America Immunocell Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 133. South America Immunocell Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 134. Middle East and Africa Immunocell Therapy Consumption Forecast by Country (2025-2032) & (Units)
Table 135. Middle East and Africa Immunocell Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 136. Global Immunocell Therapy Sales Forecast by Type (2025-2032) & (K Units)
Table 137. Global Immunocell Therapy Market Size Forecast by Type (2025-2032) & (M USD)
Table 138. Global Immunocell Therapy Price Forecast by Type (2025-2032) & (USD/Unit)
Table 139. Global Immunocell Therapy Sales (K Units) Forecast by Application (2025-2032)
Table 140. Global Immunocell Therapy Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Immunocell Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Immunocell Therapy Market Size (M USD), 2019-2032
Figure 5. Global Immunocell Therapy Market Size (M USD) (2019-2032)
Figure 6. Global Immunocell Therapy Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Immunocell Therapy Market Size by Country (M USD)
Figure 11. Immunocell Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Immunocell Therapy Revenue Share by Manufacturers in 2023
Figure 13. Immunocell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Immunocell Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Immunocell Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Immunocell Therapy Market Share by Type
Figure 18. Sales Market Share of Immunocell Therapy by Type (2019-2025)
Figure 19. Sales Market Share of Immunocell Therapy by Type in 2023
Figure 20. Market Size Share of Immunocell Therapy by Type (2019-2025)
Figure 21. Market Size Market Share of Immunocell Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Immunocell Therapy Market Share by Application
Figure 24. Global Immunocell Therapy Sales Market Share by Application (2019-2025)
Figure 25. Global Immunocell Therapy Sales Market Share by Application in 2023
Figure 26. Global Immunocell Therapy Market Share by Application (2019-2025)
Figure 27. Global Immunocell Therapy Market Share by Application in 2023
Figure 28. Global Immunocell Therapy Sales Growth Rate by Application (2019-2025)
Figure 29. Global Immunocell Therapy Sales Market Share by Region (2019-2025)
Figure 30. North America Immunocell Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Immunocell Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Immunocell Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Immunocell Therapy Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Immunocell Therapy Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Immunocell Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Immunocell Therapy Sales Market Share by Country in 2023
Figure 37. Germany Immunocell Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Immunocell Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Immunocell Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Immunocell Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Immunocell Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Immunocell Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Immunocell Therapy Sales Market Share by Region in 2023
Figure 44. China Immunocell Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Immunocell Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Immunocell Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Immunocell Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Immunocell Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Immunocell Therapy Sales and Growth Rate (K Units)
Figure 50. South America Immunocell Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Immunocell Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Immunocell Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Immunocell Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Immunocell Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Immunocell Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Immunocell Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Immunocell Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Immunocell Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Immunocell Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Immunocell Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Immunocell Therapy Production Market Share by Region (2019-2025)
Figure 62. North America Immunocell Therapy Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Immunocell Therapy Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Immunocell Therapy Production (K Units) Growth Rate (2019-2025)
Figure 65. China Immunocell Therapy Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Immunocell Therapy Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Immunocell Therapy Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Immunocell Therapy Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Immunocell Therapy Market Share Forecast by Type (2025-2032)
Figure 70. Global Immunocell Therapy Sales Forecast by Application (2025-2032)
Figure 71. Global Immunocell Therapy Market Share Forecast by Application (2025-2032)
